Werewolf Therapeutics, Inc. financial data

Symbol
HOWL on Nasdaq
Location
200 Talcott Avenue, 2 Nd Floor, Watertown, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 759 % -9.64%
Debt-to-equity 78.5 % +47.4%
Return On Equity -112 % -132%
Return On Assets -62.7 % -99.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.7M shares +4.64%
Common Stock, Shares, Outstanding 45.3M shares +3.74%
Entity Public Float 69.7M USD +3.47%
Common Stock, Value, Issued 5K USD +25%
Weighted Average Number of Shares Outstanding, Basic 45M shares +3.36%
Weighted Average Number of Shares Outstanding, Diluted 45M shares +2.13%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 54.5M USD +12%
General and Administrative Expense 18.5M USD -2.45%
Operating Income (Loss) -73M USD -25.1%
Nonoperating Income (Expense) -139K USD -103%
Net Income (Loss) Attributable to Parent -73.1M USD -36.1%
Earnings Per Share, Basic -1 USD/shares -20.6%
Earnings Per Share, Diluted -1 USD/shares -15.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 77.6M USD -42.7%
Assets, Current 80.4M USD -42%
Property, Plant and Equipment, Net 5.49M USD -22.6%
Operating Lease, Right-of-Use Asset 5.62M USD -11.5%
Other Assets, Noncurrent 122K USD -54%
Assets 92.6M USD -39.8%
Accounts Payable, Current 2.77M USD +89.1%
Employee-related Liabilities, Current 2.16M USD -4.88%
Accrued Liabilities, Current 8.54M USD -1.82%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 15.2M USD +32.6%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 8.59M USD -16.1%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 51.1M USD +2.85%
Retained Earnings (Accumulated Deficit) -451M USD -19.4%
Stockholders' Equity Attributable to Parent 41.5M USD -60.1%
Liabilities and Equity 92.6M USD -39.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.9M USD -23.9%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 45.3M shares +3.74%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -18.9M USD -491%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 78.5M USD -42.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 773K USD -15.1%
Deferred Tax Assets, Valuation Allowance 67.8M USD +44%
Deferred Tax Assets, Gross 70.3M USD +39.9%
Operating Lease, Liability 11M USD -12.8%
Depreciation 426K USD -8.19%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 13.5M USD -15.7%
Property, Plant and Equipment, Gross 11.3M USD +1.6%
Operating Lease, Liability, Current 1.45M USD +14.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.4M USD +2.82%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.34M USD -6.71%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.48M USD -26.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.47M USD +2.83%
Deferred Tax Assets, Operating Loss Carryforwards 32.8M USD +37.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.54M USD +2.87%
Additional Paid in Capital 492M USD +2.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 2.57M USD -19.7%
Share-based Payment Arrangement, Expense 7.72M USD -13.1%
Interest Expense 1M USD +483%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%